Ozet, A. Et Al. 2022. Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. FUTURE ONCOLOGY , vol.18, no.29 , 3267-3276.

Ozet, A., Dane, F., Aykan, N. F., Yalcin, S., Evrensel, T., Ozkan, M., ... Karabulut, B.(2022). Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey. FUTURE ONCOLOGY , vol.18, no.29, 3267-3276.

Ozet, AHMET Et Al. "Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey," FUTURE ONCOLOGY , vol.18, no.29, 3267-3276, 2022

Ozet, AHMET Et Al. "Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey." FUTURE ONCOLOGY , vol.18, no.29, pp.3267-3276, 2022

Ozet, A. Et Al. (2022) . "Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey." FUTURE ONCOLOGY , vol.18, no.29, pp.3267-3276.

@article{article, author={AHMET ÖZET Et Al. }, title={Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey}, journal={FUTURE ONCOLOGY}, year=2022, pages={3267-3276} }